Foldax announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial...

Foldax announced that it has executed an agreement with Australia’s national science agency, CSIRO, for full ownership of a...

Foldax Inc. announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective...

Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial...

Foldax has announced the presentation of results from the first animal study of its transcatheter valve from the TRIA...

Foldax announced publication of the first clinical results for its TRIA™ biopolymer heart valve - the first polymer valve...

Foldax® announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve. The...

Foldax announced the successful first-in-human use of its biopolymer Tria™ heart valve in surgically replacing a diseased mitral valve....

Foldax is looking to reinvent every aspect of the heart valve—from material, to design, to manufacturing. Foldax is working...

Foldax has announced the publication of a research paper in Advanced NanoBiomed Research that concluded that its LifePolymer biopolymer...